» Articles » PMID: 27413360

Multimodality Treatment in Ewing's Sarcoma Family Tumors of the Maxilla and Maxillary Sinus: Review of the Literature

Overview
Journal Sarcoma
Publisher Wiley
Date 2016 Jul 15
PMID 27413360
Citations 7
Authors
Affiliations
Soon will be listed here.
Abstract

The Ewing sarcoma family of tumors (ESFT) encompasses a group of highly aggressive, morphologically similar, malignant neoplasms sharing a common spontaneous genetic translocation that affect mostly children and young adults. These predominantly characteristic, small round-cell tumors include Ewing's sarcoma of the bone and soft tissue, as well as primitive neuroectodermal tumors (PNETs) involving the bone, soft tissue, and thoracopulmonary region (Askin's tumor). Extraosseous ESFTs are extremely rare, especially in the head and neck region, where literature to date consists of sporadic case reports and very small series. We hereby present a review of the literature published on ESFTs reported in the maxilla and maxillary sinus region from 1968 to 2016.

Citing Articles

Systemic treatment for primary malignant sarcomas arising in craniofacial bones.

Bielack S Front Oncol. 2022; 12:966073.

PMID: 36158667 PMC: 9492845. DOI: 10.3389/fonc.2022.966073.


Primary Ewing's sarcoma of sphenoid sinus: A case report and literature review.

Wu K, Zhu X, Li Y, Wen D, Wu H, Lai Y Front Oncol. 2022; 12:894833.

PMID: 36046048 PMC: 9422175. DOI: 10.3389/fonc.2022.894833.


Primary primitive neuroectodermal tumor of the cervix confirmed with molecular analysis in a pregnant woman: A case report and literature review.

Wei D, Jianguo Z, Xiao L, Pengpeng Q Front Genet. 2022; 13:871531.

PMID: 36035131 PMC: 9399424. DOI: 10.3389/fgene.2022.871531.


Ewing's Sarcoma of the Head and Neck: Margins are not just for surgeons.

Bouaoud J, Temam S, Cozic N, Galmiche-Rolland L, Belhous K, Kolb F Cancer Med. 2018; 7(12):5879-5888.

PMID: 30449071 PMC: 6308064. DOI: 10.1002/cam4.1801.


Treatment, outcomes, and demographics in sinonasal sarcoma: a systematic review of the literature.

Gore M BMC Ear Nose Throat Disord. 2018; 18:4.

PMID: 29581706 PMC: 5861608. DOI: 10.1186/s12901-018-0052-5.


References
1.
Miettinen M, Lehto V, Virtanen I . Histogenesis of Ewing's sarcoma. An evaluation of intermediate filaments and endothelial cell markers. Virchows Arch B Cell Pathol Incl Mol Pathol. 1982; 41(3):277-84. View

2.
Valdes M . On the histogenesis of Ewing's sarcoma. An ultrastructural, immunohistochemical, and cytochemical study. Cancer. 1984; 53(9):1882-901. DOI: 10.1002/1097-0142(19840501)53:9<1882::aid-cncr2820530915>3.0.co;2-y. View

3.
Hunsuck E . Ewing's sarcoma of the maxilla. Report of a case. Oral Surg Oral Med Oral Pathol. 1968; 25(6):923-8. DOI: 10.1016/0030-4220(68)90172-2. View

4.
Toda T, Atari E, Sadi A, Kiyuna M, Kojya S . Primitive neuroectodermal tumor in sinonasal region. Auris Nasus Larynx. 1999; 26(1):83-90. DOI: 10.1016/s0385-8146(98)00051-0. View

5.
Van Doorninck J, Ji L, Schaub B, Shimada H, Wing M, Krailo M . Current treatment protocols have eliminated the prognostic advantage of type 1 fusions in Ewing sarcoma: a report from the Children's Oncology Group. J Clin Oncol. 2010; 28(12):1989-94. PMC: 2860404. DOI: 10.1200/JCO.2009.24.5845. View